External Affairs Minister S Jaishankar on Wednesday said the WHO's decision to grant emergency use approval to Bharat Biotech's COVID-19 vaccine Covaxin facilitates travel for many Indian citizens and contributes to vaccine equity. He said it was also a global recognition of Prime Minister Narendra Modi's vision of an 'Atmanirbhar Bharat'.
"Welcome @WHO's decision to grant Emergency Use Listing to #COVAXIN. It facilitates travel for many Indian citizens and contributes to vaccine equity. Also a global recognition to PM @narendramodi's vision of an #AtmanirbharBharat. A Happier Diwali," Jaishankar tweeted.
@narendramodi’s vision of an #AtmanirbharBharat.A Happier Diwali.— Dr. S. Jaishankar (@DrSJaishankar) November 3, 2021
The World Health Organisation (WHO) on Wednesday granted emergency use approval for Bharat Biotech's COVID-19 vaccine Covaxin, in a move that the pharma major said is a "significant" step towards ensuring wider global access to the indigenously developed jab.
First Published: IST